Skip to content

    Breast Cancer Health Center

    Font Size

    Avastin Nixed for Breast Cancer Treatment

    The cancer drug has lost its FDA approval as a treatment for breast cancer patients. Here's why.
    WebMD Feature

    The FDA has ruled that the cancer drug Avastin is no longer approved for treating advanced breast cancer -- but can still be used for other cancers.

    In a news release, the FDA stated that Avastin "has not been shown to be safe and effective" for treating breast cancer, but that Avastin would stay on the market as an FDA-approved treatment for certain types of colon, lung, kidney, and brain cancer.

    The FDA states that Avastin's risks include severe high blood pressure; bleeding; heart attack or heart failure; and damage to different parts of the body, such as the nose, stomach, and intestines.

    The FDA started the process of removing Avastin's breast cancer indication in 2010. Genentech, the drug company that makes Avastin, appealed, completed two more studies, and submitted more data to the FDA. But now, the FDA's decision is final.

    Doctors will still have the option of using Avastin off-label to treat breast cancer, Lillie Shockney, RN, administrator of the Johns Hopkins Breast Center in Baltimore, told WebMD earlier this year. "Off-label" refers to drugs that are prescribed for uses not specifically approved by the FDA.

    Women with breast cancer who were anticipating starting therapy with Avastin must reconnect with their medical oncologist to discuss the next steps, Shockney said.

    FDA's Decision

    "This was a difficult decision," FDA commissioner Margaret Hamburg, MD, MPH, said in an FDA news release. "FDA recognizes how hard it is for patients and their families to cope with metastatic breast cancer and how great a need there is for more effective treatments. But patients must have confidence that the drugs they take are both safe and effective for their intended use.

    "After reviewing the available studies, it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects without proof that the use of Avastin will provide a benefit, in terms of delay in tumor growth, that would justify those risks," Hamburg said. "Nor is there evidence that use of Avastin will either help them live longer or improve their quality of life."

    Today on WebMD

    Breast Cancer Overview
    From mammograms to living after treatment.
    Dealing with breast cancer
    Get answers to your questions.
    woman having mammogram
    The 3 latest tips to know.
    woman undergoing breast cancer test
    Most abnormalities aren’t breast cancer.
    Resolved To Quit Smoking
    Breast Cancer Treatments Improving
    Woman getting mammogram
    Screening Tests for Women
    serious woman
    Pink badge on woman chest to support breat cancer
    what is your cancer risk
    breast cancer survivors